Cargando…
Three-dimensional culture and clinical drug responses of a highly metastatic human ovarian cancer HO-8910PM cells in nanofibrous microenvironments of three hydrogel biomaterials
BACKGROUND: Ovarian cancer is a highly aggressive malignant disease in gynecologic cancer. It is an urgent task to develop three-dimensional (3D) cell models in vitro and dissect the cell progression-related drug resistance mechanisms in vivo. In the present study, RADA16-I peptide has the reticulat...
Autores principales: | Song, Hong, Cai, Guo-hui, Liang, Jian, Ao, Di-shu, Wang, Huan, Yang, Ze-hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291456/ https://www.ncbi.nlm.nih.gov/pubmed/32527266 http://dx.doi.org/10.1186/s12951-020-00646-x |
Ejemplares similares
-
Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
por: Leng, Yun, et al.
Publicado: (2021) -
Invasiveness of mouse embryos to human ovarian cancer cells HO8910PM and the role of MMP-9
por: Ding, Xiaoyan, et al.
Publicado: (2012) -
Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro
por: Dong, Pei-Xin, et al.
Publicado: (2008) -
Knockdown of Long Noncoding RNA NR_026689 Inhibits Proliferation and Invasion and Increases Apoptosis in Ovarian Carcinoma HO-8910PM Cells
por: Zhang, Xin, et al.
Publicado: (2017) -
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the
ERK pathway
por: Bai, R.X., et al.
Publicado: (2016)